A trial looking at treatment for children and young people with acute lymphoblastic leukaemia (ALLR3)

This trial looked at treatment for children and young people with acute lymphoblastic leukaemia (ALL) that had not responded to treatment or had come back.

This trial was for children and young people between the ages of 1 to 17. We use the term 'you' in this summary, but if you are a parent, we are referring to your child.